Abstract
The administration of single-dose nevirapine to women in labor and their infants can prevent HIV-1 mother-to-child transmission. We examined nevirapine resistance in infants -who -were HIV-1 infected despite single-dose nevirapine prophylaxis, including 18 Ugandan infants (HIVNET 012 trial, nine subtype A and nine subtype D) and 23 Malawian infants (NVAZ trial, all subtype C). Nevirapine resistance was more frequent in infants with subtype C than with subtypes A and D (87 versus 50%, P = 0.016).
Original language | English (US) |
---|---|
Pages (from-to) | 2167-2169 |
Number of pages | 3 |
Journal | AIDS |
Volume | 19 |
Issue number | 18 |
DOIs | |
State | Published - Dec 2005 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases